welcome to day 2! - ecri...welcome to day 2! ann m. geiger, mph, phd associate director (acting)...
TRANSCRIPT
Welcome to Day 2!
Ann M. Geiger, MPH, PhD
Associate Director (Acting)Healthcare Delivery Research Program
Division of Cancer Control & Population Sciences
November 19, 2015
3
4
National Cancer Institute Overview
Office of the Director Informatics
Health Disparities
Cancer Centers
Intramural Cancer Epidemiology and Genetics
Cancer Research
Extramural Cancer Biology
Cancer Prevention
Cancer Treatment and Diagnosis
5
Division of Cancer Control & Population Sciences
Office of the Director Health Disparities
Implementation Science
Survivorship
Programs Behavioral
Epidemiology and Genomics
Surveillance
Patients
Healthcare Delivery Research ProgramAdvancing innovative research to improve the delivery of cancer‐related care
Established in January 2015
Patients
Healthcare Delivery Research ProgramAdvancing innovative research to improve the delivery of cancer‐related care
Outcomes Research measure, evaluate, and
improve patient experiences
Patients
Clinicians Caregivers
Payers Delivery Systems
Healthcare Delivery Research ProgramAdvancing innovative research to improve the delivery of cancer‐related care
Outcomes Research measure, evaluate, and
improve patient experiences
Health Systems & Interventions Research observe and intervene on
contextual factors
Patients
Clinicians Caregivers
Payers Delivery Systems
Healthcare Delivery Research ProgramAdvancing innovative research to improve the delivery of cancer‐related care
Outcomes Research measure, evaluate, and
improve patient experiences
Health Systems & Interventions Research observe and intervene on
contextual factors
Healthcare Assessment Research
assess utilization, diffusion, and population‐
based outcomes
HDRP Research Activities
Patterns of Care Special SEER Studies
HDRP Research Activities
Patterns of Care Special SEER Studies
Person-Centered Assessment Resource (PCAR)
HDRP Research Activities
Patterns of Care Special SEER Studies
Precision Medicine Provider Survey
Person-Centered Assessment Resource (PCAR)
HDRP Research Activities
Patterns of Care Special SEER Studies
Precision Medicine Provider Survey
Person-Centered Assessment Resource (PCAR)
HDRP Research Activities
Patterns of Care Special SEER Studies
Precision Medicine Provider Survey
Person-Centered Assessment Resource (PCAR)
NCI‐ASCO Teams in Cancer Care Delivery
HDRP Research Activities
Patterns of Care Special SEER Studies
Precision Medicine Provider Survey
Person-Centered Assessment Resource (PCAR)
NCI‐ASCO Teams in Cancer Care Delivery Examination of Survivorship Care Planning Efficacy and Impact
16
Examples of Interest Areas
Multilevel context Processes of care
Diffusion of molecularly targeted therapies Shared decision-making (and what follows) Caregiver role and outcomes Financial burden (particularly employment) Overcoming disparities in care
Supporting junior scientists
17
Challenges
Appropriations process Budget levels
Timelines
Peer review Program priorities
How are the unique capacities of NCI best used to generate evidence needed to plan for care delivery in 5 to 10 years?
www.cancer.gov www.cancer.gov/espanol